Press / Medias

LNC secure 6,5 million euros funding for microbiota-focused strategy – looking to IPO

Oct 2, 2017

LNC Therapeutics has raised €6.5m in a Series C funding round as the company announces a new chief science officer and steps up an ‘ambitious’ microbiota-orientated strategy that it hopes will drive an IPO by the end of 2019.

In the same category

Press / Medias

LNC Therapeutics selected by BNP Paribas for its innovative approach to beat obesity

Nov 12, 2019

more +
Press / Medias

Avec plus de 140 millions d’euros levés, les startups ne ratent pas leur rentrée

Sep 6, 2019

more +
Press / Medias

LNC Therapeutics raises €6.2 million for the clinical development of new generation gut microbiome...

Sep 5, 2019

more +

LNC Therapeutics © 2019 - all rights reserved terms and conditions